Clues and timeline of cleaning house of toxicity. It's

New Post Public Reply Private Reply Replies (2) Message Board
BURN.NOTICE88
1,347
Clues and timeline of cleaning house of toxicity.

It's no secret the company is seeking better financing to replace toxic convertible notes with more traditional long-term capital in the public markets. IHSI has stated such in several PRs and the financials. Imagine how this will increase the value of IHSI once these dirty notes are off the books. If or more like when successful, when it happens, it will happen overnight. Those old notes would disappear and armed with a more-typical conventional loan with lower rates, the company will grow the business with a steady stream income and further acquisitions.

I believe multiple clues indicate the debt restructuring could possibly be in motion. Based on the following signs from IHSI and the debt restructuring company IHSI touted in their "very first" tweet. Moving forward I will refer to the debt restructuring company as "Company X." IHSI's first tweet was clue number one, something is be brewing.

The second clue, which actually preceded clue one, but was meaningless without clue number two, IHSI got their financial house in order, spending 10's of thousands of dollars to get all quarterly and annual filings updated, with the 10K audited for 2016. This matches perfectly with the first article on Company X's website, "Take the Summer to Get Your Financial House in Order."

Clue number three, were consistent demands to the company by shareholders to stop the toxic lending and selling of notes into the bid. Numerous phone calls and email exchanges between concerned shareholders and IR with those thoughts, feelings and feedbacks openly shared on the board, including management's opinion, responsiveness and willingness to listen to and address shareholder concerns. This was confirmed in clue number four.

Clue number four, was the company's letter to shareholders on August 8th. In that letter, management acknowledged shareholder concerns, "As shareholders, your concerns about IHSI are the dilution, debt, stock price and reverse split. When the first quarter 10Q was filed, and outstanding shares were reported, there were shares in the pipeline that, as of the filing, were scheduled for distribution but had not yet been issued. We have consolidated our debt and we believe our relationships with the note holders is excellent. It has been an expensive process to have our reporting updated, acquire Cresent and seek other acquisition targets. But this is our future...and our investors' future. We are looking for better financing to replace these notes and we anticipate a cash flow that will support the growth of the Company and service our expenses."

This weekend I spent time, "following the money" by taking a closer look at Company X. Out popping multiple clues from Company X's webpage "What We Do." I could spend upwards of an hour building a checklist of the things Company X recommends all OTC companies facing toxic lending to do, along with the services Company X provides. Then spend more than 30 minutes connecting how I believe IHSI is checking off Company X's capital restructuring checklist. For now, I'll leave that up to you to investigate and draw your own conclusion.

To help those along a little bit, I can't help but believe the recent $1.7M lawsuit vs. the toxic lender is related. I can't help but believe the company's hiring of a professional IR firm is related. I can't help but believe that Tom Allinder coincidentally, who works for the debt restructuring company, who also assisted with the facilitation of the company website. I can't help but believe that Company X underscoring the use of social media to get the message out and now IHSI is tweeting away. I can't help but believe the recent picture I found on the interweb from the downtown investment banking district in NY is mere coincidence it originates from IHSI's website. Most of all, I can't believe how easy it was to tie all this together with just one tweet. It MAY all be mere coincidence, BUT I don't believe it is!

And oh, by the way, clock is ticking. Company X said 90 to 180 days to turn the bad debt around. By my timeline, they may have been working with Company X for several months now. Website built. Lawsuit vs. bad lender. IR firm in place. Social media check. The list goes on...

But don't take my word. Research and judge for yourself.

Happy hunting!

Intelligent Highway Solutions, Inc. (IHSI) Stock Research Links

IHSI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bramshill Fund Takes Top Spot in 2026 Fund Awards

Updated Category News Views 68

Another Feather in Bramshill's Cap They've done it again, folks. The Bramshill Multi-Strategy Income Fund has just snagged the 40 Act Fund of the Year award at the 2026 Hedge Fund Performance Awards. This ain't just another plaque for the wall; it's a nod to some serious heavy lifting by the folks handling this beast of a portfolio. The award, dished out by With...

Continue Reading
Lean Focus Expands: Bridging Global Expertise in APAC

Updated Category News Views 67

A New Era for Lean Focus in the Asia Pacific The wave of business dynamics in APAC just got a little more intense. Lean Focus has thrown its hat in the ring, expanding into the Asia Pacific—a move that could shift how businesses operate in this bustling region. Forget the corporate hype for a moment and think about what this really means: local expertise, hands-on...

Continue Reading
Lyric Health & VivaScore: Revolutionizing Care Integration

Updated Category News Views 106

Partnering for a Healthier Tomorrow Blood, sweat, and tears—health's never been for the faint of heart. Now, Lyric Health and VivaScore are teaming up to give healthcare a serious upgrade. They're not just pushing papers—these folks mean business with their brand-new strategic partnership. The synergy between the brains at VivaScore and the ecosystem that Lyric's...

Continue Reading
Andersen 400 Series Patio Door Wins 2027 Award

Updated Category News Views 94

Andersen's Winning Streak Continues Ever got that feeling when you see an old player pulling off a brand-new trick in the game they love? That's kind of what Andersen Windows just pulled off with their 400 Series patio door snagging the 2027 Home Reno Award from Good Housekeeping. You could say Andersen's figured out how to keep the classics fresh without losing that...

Continue Reading
SEEKINK Dazzles with Game-Changing ePaper Innovations

Updated Category News Views 42

A New Dawn for ePaper Technology In the whirlwind of the Electronica 2026 expo in Munich, it wasn’t some Silicon Valley juggernaut, but SEEKINK and TOPTE making headlines with their cutting-edge ePaper innovations. These folks may be quiet players, but with hall fans stirred and tongues wagging at Hall B6 Booth 518, they're changing the game in sustainable display tech....

Continue Reading
Hexnode XDR Expands Threat Detection, MacOS Support

Updated Category News Views 78

Hexnode XDR: A Game Changer for MacOS Threats Ever heard of Hexnode? Well, today's chat is all about them beefing up their XDR platform. They’ve sagely added support for macOS—finally given the platform some love alongside Windows. It's about time! This move is a big win for everyone whose daily grind depends on keeping threats at bay across platforms. We’re talking...

Continue Reading
Accro's Vitiligo Trial Moves Fast with Fosun's Boost

Updated Category News Views 50

Launching into Vitiligo Treatment Trials I'll tell you, the biotech world isn't for the faint-hearted, especially when you're juggling hefty terms like 'TYK2/JAK1'. But here we are, watching Accro Bioscience and Fosun Pharma dive headlong into the vitiligo space with this Phase II/III trial of AC-201. They've bagged the IND clearance, and now the first patient is in the...

Continue Reading
Viatris Engages Investors at Key Healthcare Conferences

Updated Category News Views 22

Viatris Steps Into the Limelight Across Conferences Investors, listen up—Viatris Inc. is about to spill some beans at a trio of high-stakes healthcare gatherings. Set to rub elbows with the who's who of the biopharma world, this global healthcare crusader's on a mission. They're lining up to have face time at the UBS Global Biopharma Conference, the Jefferies Global...

Continue Reading
IASO Bio's In Vivo CAR-T: A Game Changer for Oncology?

Updated Category News Views 21

You ever feel like you're watching history happen right in front of you? That's the vibe with IASO Bio's latest move in the realm of oncology. This outfit just scored a major victory, getting China's NMPA and the U.S. FDA to greenlight their IASO208, a CD20-targeting in vivo CAR-T therapy. It's not every day you see a company land dual regulatory nods like...

Continue Reading
The DOG CATCHER: A New Spin on Pet Waste Cleanup

Updated Category News Views 43

Revolutionizing the Dreaded Pet Waste Duty Folks, here's a little dose of innovation from the streets of Baltimore: a gadget called the DOG CATCHER. No, it’s not about catching stray dogs, but dealing with their unpleasant leavings. This invention's got a patent pending and all, promising to make the nasty business of dog waste collection a whole lot less disgusting. I...

Continue Reading

Top 5 Most Recently Viewed Articles

Revature Secures Top Honors in HCM Excellence Awards 2025

Updated Category News Views 204

Revature Shines at the HCM Excellence Awards 2025 Revature, a leader in technology talent development, recently celebrated remarkable success at the HCM Excellence Awards 2025. With a relentless drive for excellence and innovation, the company earned two Gold awards and one Silver award for its outstanding contributions in Learning and Development. Categories and...

Continue Reading
BAB, Inc. Declares Cash Distribution for Shareholders

Updated Category News Views 114

BAB, Inc. Declares Quarterly Cash Distribution BAB, Inc. (OTCQB: BABB), headquartered in Deerfield, Illinois, recently announced an exciting update for its shareholders. The company’s Board of Directors has declared a quarterly cash distribution of one cent ($0.01) per share. This distribution is payable on a set date and represents a steadfast commitment to its...

Continue Reading
MasterBrand's Financial Report: Steady Progress in Q3 2024

Updated Category News Views 68

MasterBrand's Q3 2024 Financial Highlights MasterBrand, Inc. (NYSE: MBC) recently unveiled its financial results for the third quarter of 2024, demonstrating resilience despite various market challenges. As the largest residential cabinet manufacturer in North America, MasterBrand reported net sales of $718.1 million, reflecting a 6% increase compared to the previous...

Continue Reading
Nexalin Technology Teams Up with UCSD on Clinical Trial of Gen-3 Halo Headset

Updated Category News Views 92

Nexalin Technology and UCSD Collaborate on Innovative Clinical Trial Nexalin Technology, Inc. (NASDAQ: NXL; NXLIW) has exciting news to share as they embark on a groundbreaking clinical trial in collaboration with the University of California, San Diego. This trial, led by Dr. Ming Xiong Huang, aims to provide veterans with advanced treatment options for mild Traumatic...

Continue Reading
Boardwalk REIT Highlights Strong Performance and Growth Plans

Updated Category News Views 172

Boardwalk REIT Shares Insights on Leasing and Investments Boardwalk Real Estate Investment Trust (TSX: BEI.UN) provides detailed updates on its leasing performance and capital allocation strategies. In the typically slower winter months, the Trust has maintained its focus on high occupancy rates and enhancing Resident Member retention. As the new year approaches,...

Continue Reading